[
    [
        {
            "time": "2021-01-29",
            "orginal_text": "晨会聚焦210129重点关注哔哩哔哩、拉卡拉、华测检测、泰格医药、连城数控",
            "features": {
                "keywords": [
                    "泰格医药",
                    "晨会聚焦",
                    "重点公司"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "晨会聚焦210129重点关注哔哩哔哩、拉卡拉、华测检测、泰格医药、连城数控",
            "scores": {
                "News_content": "晨会聚焦210129重点关注哔哩哔哩、拉卡拉、华测检测、泰格医药、连城数控",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-12-31",
            "orginal_text": "【天风医药】泰格医药：2020年实现快速增长，2021年有望更进一步",
            "features": {
                "keywords": [
                    "泰格医药",
                    "快速增长",
                    "2021展望"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "【天风医药】泰格医药：2020年实现快速增长，2021年有望更进一步",
            "scores": {
                "News_content": "【天风医药】泰格医药：2020年实现快速增长，2021年有望更进一步",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-01-15",
            "orginal_text": "【权益变动】泰格医药(03347-HK)被NINETONEUKLIMITED减持12.18万股 减持股份",
            "features": {
                "keywords": [
                    "泰格医药",
                    "权益变动",
                    "减持"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "【权益变动】泰格医药(03347-HK)被NINETONEUKLIMITED减持12.18万股 减持股份",
            "scores": {
                "News_content": "【权益变动】泰格医药(03347-HK)被NINETONEUKLIMITED减持12.18万股 减持股份",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-01-10",
            "orginal_text": "医药生物行业：药品集采常态化 坚定拥抱医药创新",
            "features": {
                "keywords": [
                    "药品集采",
                    "医药创新"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药生物行业：药品集采常态化 坚定拥抱医药创新",
            "scores": {
                "News_content": "医药生物行业：药品集采常态化 坚定拥抱医药创新",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-01-20",
            "orginal_text": "泰格医药（300347）2020年业绩预告点评：主营业务持续恢复，非经常性收益较高",
            "features": {
                "keywords": [
                    "泰格医药",
                    "业绩预告",
                    "主营业务恢复"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "泰格医药（300347）2020年业绩预告点评：主营业务持续恢复，非经常性收益较高",
            "scores": {
                "News_content": "泰格医药（300347）2020年业绩预告点评：主营业务持续恢复，非经常性收益较高",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]